[Detection of HTLV-I proviral DNA by PCR method from bronchoalveolar lavage cells of HTLV-I carriers]. 1994

S Mori, and H Fukunaga, and I Maruyama, and T Takaoka, and Y Koreeda, and F Iwami, and Y Hirotsu, and A Mizoguchi, and S Kawabata, and M Osame
Department of Internal Medicine, Minamikyusyu Hospital National Sanatorium, Kagoshima, Japan.

To elucidate whether or not human T-lymphotropic virus type I (HTLV-I) infected cells exist in the lungs of HTLV-I carriers, we examined bronchoalveolar lavage (BAL) cells for the presence of HTLV-I proviral DNA by the polymerase chain reaction (PCR) method. The cells were harvested from HTLV-I seropositive individuals with or without various respiratory diseases. The HTLV-I pX region was detected from separated BAL cells by dot blot hybridization after PCR in all 14 HTLV-I seropositive individuals tested. Four out of these 14 individuals were asymptomatic HTLV-I carriers, while the other ten had symptoms, including those of bacterial pneumonia, chronic respiratory tract infection, interstitial pneumonia, atypical mycobacterial infection, bronchitis, mediastinal lymphadenitis and bronchial asthma. HTLV-I proviral DAN was detected in BAL cells from patients with a normal proportion of lavage lymphocytes and a normal CD4/CD8 ratio. These findings suggest that HTLV-I infected cells may commonly exist in the lower respiratory tract and alveolar space without producing characteristic symptoms/signs, and that any causal relation to the pulmonary lesion must therefore be carefully elucidated, in HTLV-I carriers.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011024 Pneumonia, Viral Inflammation of the lung parenchyma that is caused by a viral infection. Pneumonias, Viral,Viral Pneumonia,Viral Pneumonias
D011533 Proviruses Duplex DNA sequences in eukaryotic chromosomes, corresponding to the genome of a virus, that are transmitted from one cell generation to the next without causing lysis of the host. Proviruses are often associated with neoplastic cell transformation and are key features of retrovirus biology. Provirus
D001992 Bronchoalveolar Lavage Fluid Washing liquid obtained from irrigation of the lung, including the BRONCHI and the PULMONARY ALVEOLI. It is generally used to assess biochemical, inflammatory, or infection status of the lung. Alveolar Lavage Fluid,Bronchial Lavage Fluid,Lung Lavage Fluid,Bronchial Alveolar Lavage Fluid,Lavage Fluid, Bronchial,Lavage Fluid, Lung,Pulmonary Lavage Fluid,Alveolar Lavage Fluids,Bronchial Lavage Fluids,Bronchoalveolar Lavage Fluids,Lavage Fluid, Alveolar,Lavage Fluid, Bronchoalveolar,Lavage Fluid, Pulmonary,Lavage Fluids, Alveolar,Lavage Fluids, Bronchial,Lavage Fluids, Bronchoalveolar,Lavage Fluids, Lung,Lavage Fluids, Pulmonary,Lung Lavage Fluids,Pulmonary Lavage Fluids
D002353 Carrier State The condition of harboring an infective organism without manifesting symptoms of infection. The organism must be readily transmissible to another susceptible host. Asymptomatic Carrier State,Asymptomatic Infection Carrier,Inapparent Infection Carrier,Presymptomatic Carrier State,Presymptomatic Infection Carrier,Super-spreader Carrier,Superspreader Carrier,Asymptomatic Carrier States,Asymptomatic Infection Carriers,Carrier State, Asymptomatic,Carrier State, Presymptomatic,Carrier States,Carrier, Super-spreader,Carrier, Superspreader,Carriers, Super-spreader,Carriers, Superspreader,Inapparent Infection Carriers,Infection Carrier, Asymptomatic,Infection Carrier, Inapparent,Infection Carrier, Presymptomatic,Presymptomatic Carrier States,Presymptomatic Infection Carriers,Super spreader Carrier,Super-spreader Carriers,Superspreader Carriers
D004279 DNA, Viral Deoxyribonucleic acid that makes up the genetic material of viruses. Viral DNA
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly

Related Publications

S Mori, and H Fukunaga, and I Maruyama, and T Takaoka, and Y Koreeda, and F Iwami, and Y Hirotsu, and A Mizoguchi, and S Kawabata, and M Osame
July 1992, Nihon rinsho. Japanese journal of clinical medicine,
S Mori, and H Fukunaga, and I Maruyama, and T Takaoka, and Y Koreeda, and F Iwami, and Y Hirotsu, and A Mizoguchi, and S Kawabata, and M Osame
January 2001, Dermatology (Basel, Switzerland),
S Mori, and H Fukunaga, and I Maruyama, and T Takaoka, and Y Koreeda, and F Iwami, and Y Hirotsu, and A Mizoguchi, and S Kawabata, and M Osame
January 1997, American journal of hematology,
S Mori, and H Fukunaga, and I Maruyama, and T Takaoka, and Y Koreeda, and F Iwami, and Y Hirotsu, and A Mizoguchi, and S Kawabata, and M Osame
June 2001, Journal of clinical microbiology,
S Mori, and H Fukunaga, and I Maruyama, and T Takaoka, and Y Koreeda, and F Iwami, and Y Hirotsu, and A Mizoguchi, and S Kawabata, and M Osame
January 1994, Microbiology and immunology,
S Mori, and H Fukunaga, and I Maruyama, and T Takaoka, and Y Koreeda, and F Iwami, and Y Hirotsu, and A Mizoguchi, and S Kawabata, and M Osame
November 1991, The Journal of infectious diseases,
S Mori, and H Fukunaga, and I Maruyama, and T Takaoka, and Y Koreeda, and F Iwami, and Y Hirotsu, and A Mizoguchi, and S Kawabata, and M Osame
January 2000, Respiration; international review of thoracic diseases,
S Mori, and H Fukunaga, and I Maruyama, and T Takaoka, and Y Koreeda, and F Iwami, and Y Hirotsu, and A Mizoguchi, and S Kawabata, and M Osame
September 1986, [Rinsho ketsueki] The Japanese journal of clinical hematology,
S Mori, and H Fukunaga, and I Maruyama, and T Takaoka, and Y Koreeda, and F Iwami, and Y Hirotsu, and A Mizoguchi, and S Kawabata, and M Osame
May 1995, Journal of clinical microbiology,
S Mori, and H Fukunaga, and I Maruyama, and T Takaoka, and Y Koreeda, and F Iwami, and Y Hirotsu, and A Mizoguchi, and S Kawabata, and M Osame
February 1993, The American journal of tropical medicine and hygiene,
Copied contents to your clipboard!